FDA Approval of Penpulimab-kcqx for Nasopharyngeal Carcinoma by Oncology's Green Light Tune in to learn about penpulimab-kcqx, a significant advancement recently approved by the FDA for treating non-keratinizing metastatic nasopharyngeal carcinoma (NPC). This episode delves into the sci...

Tune in to the latest episode to learn about the FDA approval of penpulimab-kcqx for non-keratinizing metastatic nasopharyngeal carcinoma (NPC) #NPCCancer #Immunotherapy #Penpulimab #CancerTreatment #FDAApproval #Oncology #Podcast #FDA
creators.spotify.com/pod/show/onc...